Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

 

    Related Conference of Vaccines for Immune Mediated Diseases

    October 30-31, 2020

    32nd Annual Congress on Immunology and Vaccinations

    Vancouver, Canada

    Vaccines for Immune Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in